- Home
- DVAX vs SCS Comparison
DVAX vs SCS Comparison
Compare DVAX & SCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DVAX
- SCS
- Stock Information
- Founded
- DVAX 1996
- SCS 1912
- Country
- DVAX United States
- SCS United States
- Employees
- DVAX N/A
- SCS N/A
- Industry
- DVAX Biotechnology: Pharmaceutical Preparations
- SCS Office Equipment/Supplies/Services
- Sector
- DVAX Health Care
- SCS Consumer Discretionary
- Exchange
- DVAX Nasdaq
- SCS Nasdaq
- Market Cap
- DVAX 1.5B
- SCS 1.6B
- IPO Year
- DVAX 2004
- SCS 1998
- Fundamental
- Price
- DVAX $12.21
- SCS $13.23
- Analyst Decision
- DVAX Buy
- SCS Strong Buy
- Analyst Count
- DVAX 2
- SCS 2
- Target Price
- DVAX $22.00
- SCS $17.00
- AVG Volume (30 Days)
- DVAX 3.3M
- SCS 471.8K
- Earning Date
- DVAX 11-07-2024
- SCS 12-17-2024
- Dividend Yield
- DVAX N/A
- SCS 3.02%
- EPS Growth
- DVAX N/A
- SCS 125.40
- EPS
- DVAX 0.15
- SCS 1.06
- Revenue
- DVAX $260,810,000.00
- SCS $3,136,200,000.00
- Revenue This Year
- DVAX $23.13
- SCS $2.70
- Revenue Next Year
- DVAX $19.60
- SCS $3.08
- P/E Ratio
- DVAX $80.80
- SCS $12.48
- Revenue Growth
- DVAX N/A
- SCS N/A
- 52 Week Low
- DVAX $9.74
- SCS $11.50
- 52 Week High
- DVAX $15.01
- SCS $14.74
- Technical
- Relative Strength Index (RSI)
- DVAX 52.22
- SCS 55.58
- Support Level
- DVAX $11.61
- SCS $13.07
- Resistance Level
- DVAX $13.74
- SCS $13.99
- Average True Range (ATR)
- DVAX 0.52
- SCS 0.32
- MACD
- DVAX 0.09
- SCS 0.11
- Stochastic Oscillator
- DVAX 32.80
- SCS 61.42
About DVAX Dynavax Technologies Corporation
Dynavax Technologies Corp is a biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. Its current product candidates are being investigated for use in multiple cancer indications as a vaccine for the prevention of HEPLISAV-B (Hepatitis B Vaccine (Recombinant), Adjuvanted), operates in the business segment of discovery, development, and commercialization of novel vaccines. Its Toll-like Receptor Immune Modulation Platform technology plays a vital role in innate immunity and subsequent adaptive immunity. The company generates the vast majority of its revenue from the sale of its CpG 1018 product and HEPLISAV-B.
About SCS Steelcase Inc.
Steelcase Inc is a furniture company based in the United States. Its brands such as Steelcase, AMQ, Coalesse, Designtex, and others offer a portfolio of furniture and architectural products and services designed to help customers create workplaces. It markets its products and services to businesses and organizations predominantly through a network of dealers and also sells to consumers in markets around the world through web-based and retail distribution channels. The company's reportable segments include the Americas which generates key revenue, and International.